Sab Biotherapeutics Stock Technical Analysis
| SABS Stock | USD 1.53 0.09 5.56% |
As of the 27th of March, SAB Biotherapeutics owns the Information Ratio of (0.08), coefficient of variation of (1,337), and Market Risk Adjusted Performance of (0.74). In respect to fundamental indicators, the technical analysis model makes it possible for you to check possible technical drivers of SAB Biotherapeutics, as well as the relationship between them. Please validate SAB Biotherapeutics mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if SAB Biotherapeutics is priced fairly, providing market reflects its prevailing price of 1.53 per share. Please also confirm SAB Biotherapeutics jensen alpha, which is currently at (0.68) to double-check the company can sustain itself in the future.
SAB Biotherapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as SAB, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SABSAB |
SAB Biotherapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.4 | Strong Buy | 5 | Odds |
Most SAB analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand SAB stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of SAB Biotherapeutics, talking to its executives and customers, or listening to SAB conference calls.
SAB Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
SAB Biotherapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of SAB Biotherapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
SAB Biotherapeutics Trend Analysis
Use this graph to draw trend lines for SAB Biotherapeutics. You can use it to identify possible trend reversals for SAB Biotherapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual SAB Biotherapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.SAB Biotherapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for SAB Biotherapeutics applied against its price change over selected period. The best fit line has a slop of 0.05 , which may suggest that SAB Biotherapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 90.55, which is the sum of squared deviations for the predicted SAB Biotherapeutics price change compared to its average price change.About SAB Biotherapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of SAB Biotherapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of SAB Biotherapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on SAB Biotherapeutics price pattern first instead of the macroeconomic environment surrounding SAB Biotherapeutics. By analyzing SAB Biotherapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of SAB Biotherapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to SAB Biotherapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 1.43 | 1.13 | 1.3 | 1.91 | Revenue Per Share | 5.49 | 0.41 | 0.47 | 0.44 |
SAB Biotherapeutics March 27, 2025 Technical Indicators
Most technical analysis of SAB help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for SAB from various momentum indicators to cycle indicators. When you analyze SAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.74) | |||
| Mean Deviation | 5.19 | |||
| Coefficient Of Variation | (1,337) | |||
| Standard Deviation | 8.93 | |||
| Variance | 79.67 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.75) | |||
| Maximum Drawdown | 71.75 | |||
| Value At Risk | (8.67) | |||
| Potential Upside | 11.72 | |||
| Skewness | (2.80) | |||
| Kurtosis | 17.31 |
SAB Biotherapeutics March 27, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as SAB stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 857.30 | ||
| Daily Balance Of Power | (0.90) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 1.58 | ||
| Day Typical Price | 1.56 | ||
| Price Action Indicator | (0.09) |
Additional Tools for SAB Stock Analysis
When running SAB Biotherapeutics' price analysis, check to measure SAB Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SAB Biotherapeutics is operating at the current time. Most of SAB Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of SAB Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SAB Biotherapeutics' price. Additionally, you may evaluate how the addition of SAB Biotherapeutics to your portfolios can decrease your overall portfolio volatility.